European personal fairness agency Nordic Capital has acquired a majority stake in knowledge analytics firm Arcadia by means of a newly introduced strategic partnership.
Boston-based Arcadia is a healthcare knowledge platform that amasses knowledge from throughout the business and makes use of superior analytics, AI and efficiency benchmarking to assist payers and suppliers enhance care high quality, decrease prices and improve income.
Nordic Capital, headquartered in Stockholm, says that beneath its umbrella, Arcadia will be capable of speed up its enlargement. The deal is anticipated to shut within the latter half of 2025.
The acquisition marks an exit for earlier investor Peloton Fairness, whose predecessor agency Ferrer Freeman acquired Arcadia Options in 2012.
“Nordic Capital’s funding is a robust endorsement of the power of Arcadia’s platform and confidence in our skill to ship worth by bettering outcomes and lowering prices,” Michael Meucci, Arcadia’s president and CEO, mentioned in an announcement.
“This milestone marks a brand new part of development for Arcadia, grounded in the identical mission, however with even stronger backing to scale smarter, make investments quicker, and speed up innovation to satisfy the rising demand for data-driven intelligence in healthcare.”
THE LARGER TREND
Final 12 months, California-based real-world knowledge platform Atropos Well being introduced that Arcadia joined its well being portfolio, giving Arcadia’s supplier clients and life sciences customers entry to Atropos’ choices.
Atropos presents AI instruments, proof era, analytics augmentation and knowledge analysis to assist physicians entry real-world proof to information scientific selections and analysis.
In 2023, GuideHealth, an AI-enabled value-based care supplier for well being programs, introduced it acquired Arcadia’s value-based care companies division and managed companies group.
GuideHealth additionally signed an settlement with Arcadia to make use of its knowledge analytics platform to energy the acquired choices, which is able to work with its predictive and generative AI.
That very same 12 months, Arcadia secured $125 million in funding, and three years earlier than, obtained a $29.5 million development fairness funding.
Along with Arcadia, Nordic Capital’s portfolio consists of different healthcare-focused corporations, together with life sciences firm ArisGlobal, scientific trial administration platform Clario, scientific analysis group Cytel, and pharma-company targeted knowledge and expertise agency IntegriChain.
